Med-Tech Innovation November 22, 2023

Meridian Medical Technologies, a division of Kindeva Drug Delivery, has been awarded a $9.9 million contract to supply DuoDote to the Administration for Strategic Preparedness and Response (ASPR) within the United States (U.S.) Department of Health and Human Services.

Meridian is a health security and chemical, biological, radiological, and nuclear (CBRN) medical countermeasure provider. DuoDote is an FDA-approved dual-chamber autoinjector (atropine and pralidoxime chloride) chemical nerve agent antidote. Meridian supplies DuoDote to U.S. and allied ministries of health and defence, as well as hospitals and civilian first responder agencies.

As part of its role in the federal response, ASPR ensures the availability and rapid deployment of lifesaving pharmaceuticals, antidotes, and other...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, HHS, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article